Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs

被引:0
|
作者
Djordjevic, J
Michniak, B
Uhrich, KE
机构
[1] Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA
来源
AAPS PHARMSCI | 2003年 / 5卷 / 04期
关键词
topical drug delivery; NSAIDs; polymeric micelle; permeation; drug release;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to evaluate amphiphilic star-like macromolecules (ASMs) as a topical drug delivery system. Indomethacin, piroxicam, and ketoprofen were individually encapsulated into the ASMs using coprecipitation. The effects of the ASMs on percutaneous permeation of nonsteroidal anti-inflammatory drugs (NSAIDs) across full thickness, hairless mouse skin were evaluated in vitro using modified Franz diffusion cells. In addition, solubility and in vitro release experiments were performed to characterize ASMs behavior in aqueous media. Poly(ethylene glycol) (PEG) and Pluronic P-85 were used as polymer controls to compare the role of PEG and amphiphilic behavior in the ASMs. In vitro release experiments indicated that ASMs can delay drug release (P <.05), whereas solubility measurements showed that ASMs can increase NSAIDs aqueous solubility (P <.05). Percutaneous permeation studies revealed that ASMs decreased both flux and Q(24) of drugs compared with the control (P <. 10). Skin pretreatment studies with ASM-containing solution before drug application demonstrated that pretreatment similarly influenced NSAID percutaneous permeation. In conclusion, ASMs likely slow drug permeation through 2 mechanisms, delayed drug diffusion from its core and skin dehydration by its shell. Thus, ASMs may be useful for delayed dermal delivery or prevention of compound permeation through the skin (eg, sunscreens, N,N-diethyl-m-toluamide [DEET]) from aqueous formulations.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs
    Jelena Djordjevic
    Bozena Michniak
    Kathryn E. Uhrich
    AAPS PharmSci, 5 (4):
  • [2] Topical nonsteroidal anti-inflammatory drugs
    Bhat, Chirag
    Rosenberg, Hans
    James, Daniel
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (36) : E1231 - E1231
  • [3] Multiple emulsions as carriers for the topical delivery of anti-inflammatory drugs
    Markowska-Radomska, Agnieszka
    Skowronski, Patryk
    Kosicki, Konrad
    Dluska, Ewa
    CHEMICAL AND PROCESS ENGINEERING-NEW FRONTIERS, 2023, 44 (03):
  • [4] Topical Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis
    Barthel, H. Richard
    Axford-Gatley, Robert A.
    POSTGRADUATE MEDICINE, 2010, 122 (06) : 98 - 106
  • [5] Topical Nonsteroidal Anti-Inflammatory Drugs #249
    Merriam, Sarah
    Claxton, Rene
    JOURNAL OF PALLIATIVE MEDICINE, 2012, 15 (05) : 612 - 613
  • [6] Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome
    Barkin, Robert L.
    AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (05) : 388 - 407
  • [7] Novel nonsteroidal anti-inflammatory drugs
    Boutsen, Y
    Esselinckx, W
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1999, 62 (04): : 421 - 424
  • [8] Use of mesoporous carriers for nonsteroidal anti-inflammatory drugs
    Geszke-moritz, Matgorzata
    Moritz, Michat
    PRZEMYSL CHEMICZNY, 2024, 103 (08):
  • [9] Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
    Russo, Andrea
    Costagliola, Ciro
    Delcassi, Luisa
    Parmeggiani, Francesco
    Romano, Mario R.
    dell'Omo, Roberto
    Semeraro, Francesco
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [10] Safety of Oral and Topical Nonsteroidal Anti-Inflammatory Drugs
    Faber, Sara
    Brown, Alexandria
    Cottreau, Jessica
    ORTHOPAEDIC NURSING, 2024, 43 (04) : 234 - 237